Vistin Pharma ASA (LTS:0RAM)
kr 27.6 0 (0%) Market Cap: 1.18 Bil Enterprise Value: 1.18 Bil PE Ratio: 19.84 PB Ratio: 3.90 GF Score: 72/100

Q3 2021 Vistin Pharma ASA Earnings Call Transcript

Oct 28, 2021 / 06:30AM GMT
Release Date Price: kr20.8
Operator

Good day, and thank you for standing by. Welcome to the Vistin Pharma quarterly report Q3 2021. (Operator Instructions) Please be advised today's conference is being recorded.

I would now like to hand the conference over to your speaker today, Kjell-Erik Nordby. Please go ahead.

Kjell;Erik Nordby
Vistin Pharma ASA - CEO

Thank you very much, and welcome to Vistin Pharma third quarter reporting. The presentation will be held by myself, Kjell-Erik Nordby, the CEO of the company; and Alexander Karlsen, the CFO.

So first, we start with the highlights for the quarter. We continue to deliver strong revenues also in the third quarter. The revenue for the quarter ended at NOK 63 million compared to NOK 55 million the last -- the third quarter last year, which is a 14% increase in revenue. And the increase was driven by, first of all, higher sales volume and also higher sales prices, which was partly offset by a significant stronger Norwegian kroner versus euro in the quarter. And year-to-date, we have achieved more than NOK 200

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot